Hepatitis A Vaccine (Human Diploid Cell), Inactivated(Merck & Co.)

甲型肝炎灭活疫苗(人二倍体细胞)(Merck & Co.)

Report date: 2025/10/15 17:32:35

Base Information

Drug NameHepatitis A Vaccine (Human Diploid Cell), Inactivated(Merck & Co.)

Drug Alias NameHepatitis A vaccine, inactivated (Merck & Co.)灭活甲型肝炎病毒（mo）Vaqta维康特

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis A

Global Approved IndicationsHepatitis A

Approved Indications in ChinaHepatitis A

Original Approved Country/TerritoryEU

Original Approved Date1996/01/01

Country/TerritoryUnited StatesEUMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesMerck Sharp & Dohme Corp

China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co Inc

Inactive CompaniesN/A

Active IndicationsHepatitis A

Inactive IndicationsN/A

Other Information

ATC CodeJ07BC02